Vanberra Signal

Genome Cruzer

Curated by Signal

Platform for integrative 3D visualization and analysis of complex and multidimensional molecular data

Overview

Genome Cruzer is an integrative 3D data visualization and analysis platform based on Kairos3D's Gilgamesh technology for the analysis and exploration of large multi-dimensional molecular datasets. The Genome Cruzer platform is a tri-dimensional environment in which different types of information, such as gene expression, dosage, microRNA expression and clinical data can be encoded into morphological features and concomitantly visualized. The 3D-environment is intuitive and interactive, and it enables capturing, visualizing and navigating even an entire dataset, effectively showing global mRNA, miRNA and Copy Number Alteration (CNA) data for hundreds of patients in one screen view. It also enables selection of objects and groups and visualization and analysis of relationships between them.

Key facts

Founded
2012
Headquarters
Turin, Italy

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Developer of a micro-physiological platform for advanced in-vitro studies

    Health TechnologyMilan, Italy
  • Cloud-based dental surgery workflow management solution for dentists

    Health TechnologyCantu, Italy
  • Digital practice management system for hospitals

    Health TechnologyItaly

About Genome Cruzer

What does Genome Cruzer do?

Genome Cruzer is an integrative 3D data visualization and analysis platform based on Kairos3D's Gilgamesh technology for the analysis and exploration of large multi-dimensional molecular datasets.

Where is Genome Cruzer headquartered?

Genome Cruzer is headquartered in Turin, Italy.

When was Genome Cruzer founded?

Genome Cruzer was founded in 2012.

Which sector is Genome Cruzer in?

Genome Cruzer operates in Health Technology.

Who are Genome Cruzer's competitors?

Companies similar to Genome Cruzer include TToP, 3Diemme, and MiCRoM.